Wendy Cai

637 total citations
8 papers, 493 citations indexed

About

Wendy Cai is a scholar working on Immunology, Rheumatology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Wendy Cai has authored 8 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Rheumatology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Wendy Cai's work include Systemic Lupus Erythematosus Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and T-cell and B-cell Immunology (3 papers). Wendy Cai is often cited by papers focused on Systemic Lupus Erythematosus Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and T-cell and B-cell Immunology (3 papers). Wendy Cai collaborates with scholars based in United States and China. Wendy Cai's co-authors include John Zhong, Cecil Chen, William W. Freimuth, Arthur Weinstein, Winn Chatham, William Stohl, W. Joseph McCune, Joan T. Merrill, Michael A. Becker and Richard Furie and has published in prestigious journals such as Neurology, The Journal of Infectious Diseases and Toxicological Sciences.

In The Last Decade

Wendy Cai

8 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wendy Cai United States	7	337	282	265	51	45	8	493
Bisram Deocharan United States	11	353 1.0×	316 1.1×	203 0.8×	17 0.3×	58 1.3×	14	533
Carl Harald Janson Sweden	11	384 1.1×	45 0.2×	110 0.4×	24 0.5×	46 1.0×	19	597
Luis M. Vilá United States	9	336 1.0×	308 1.1×	89 0.3×	14 0.3×	77 1.7×	11	565
Satoshi Shiokawa Japan	10	227 0.7×	35 0.1×	100 0.4×	85 1.7×	38 0.8×	24	375
Alka Patel United Kingdom	7	434 1.3×	107 0.4×	28 0.1×	16 0.3×	132 2.9×	9	633
Diahann T. S. L. Jansen Netherlands	13	190 0.6×	151 0.5×	69 0.3×	31 0.6×	50 1.1×	20	401
R. Coldewey Germany	9	185 0.5×	185 0.7×	81 0.3×	17 0.3×	42 0.9×	14	327
Eduard Graell Spain	10	144 0.4×	276 1.0×	39 0.1×	51 1.0×	27 0.6×	12	374
Elaine C. Jolly United Kingdom	6	194 0.6×	41 0.1×	71 0.3×	41 0.8×	63 1.4×	12	385
Quentin Simon France	10	335 1.0×	66 0.2×	47 0.2×	18 0.4×	63 1.4×	17	514

Countries citing papers authored by Wendy Cai

Since Specialization

Citations

This map shows the geographic impact of Wendy Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Cai more than expected).

Fields of papers citing papers by Wendy Cai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Cai. The network helps show where Wendy Cai may publish in the future.

Co-authorship network of co-authors of Wendy Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy Cai. A scholar is included among the top collaborators of Wendy Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy Cai. Wendy Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Cai, Wendy, et al.. (2014). Lamotrigine, a Narrow Therapeutic Index Drug or Not? (P4.267). Neurology. 82(10_supplement). 1 indexed citations

Cai, Wendy, et al.. (2013). Bioavailability, Pharmacokinetics, and Safety of Belimumab Administered Subcutaneously in Healthy Subjects. Clinical Pharmacology in Drug Development. 2(4). 349–357. 24 indexed citations

Struemper, Herbert, Cecil Chen, & Wendy Cai. (2013). Population Pharmacokinetics of Belimumab Following Intravenous Administration in Patients With Systemic Lupus Erythematosus. The Journal of Clinical Pharmacology. 53(7). 711–720. 44 indexed citations

Cai, Wendy, Lin Wang, & Yuanxiu Chen. (2010). Aspartyl Aminopeptidase, Encoded by an Evolutionarily Conserved Syntenic Gene, Is Colocalized with Its Cluster in Secretory Granules of Pancreatic Islet Cells. Bioscience Biotechnology and Biochemistry. 74(10). 2050–2055. 7 indexed citations

Devalaraja, Madhav N., et al.. (2009). Developmental and peri-postnatal study in cynomolgus monkeys with belimumab, a monoclonal antibody directed against B-lymphocyte stimulator. Reproductive Toxicology. 28(4). 443–455. 41 indexed citations

Lalezari, Jacob, Gopal Yadavalli, Michael F. Para, et al.. (2008). Safety, Pharmacokinetics, and Antiviral Activity of HGS004, a Novel Fully Human IgG4 Monoclonal Antibody against CCR5, in HIV‐1–Infected Patients. The Journal of Infectious Diseases. 197(5). 721–727. 58 indexed citations

Furie, Richard, William Stohl, Ellen M. Ginzler, et al.. (2008). Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus. Arthritis Research & Therapy. 10(5). R109–R109. 205 indexed citations

Halpern, Wendy, Patrick B. Lappin, Thomas A. Zanardi, et al.. (2006). Chronic Administration of Belimumab, a BLyS Antagonist, Decreases Tissue and Peripheral Blood B-Lymphocyte Populations in Cynomolgus Monkeys: Pharmacokinetic, Pharmacodynamic, and Toxicologic Effects. Toxicological Sciences. 91(2). 586–599. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact